Pomerantz LLP is investigating claims on behalf of investors of  Laser Photonics Corporation ("Laser Photonics" or the "Company") .  Such investors are advised to contact Danielle Peyton at ...

Pomerantz LLP is investigating claims on behalf of investors of  Eos Energy Enterprises, Inc. ("Eos" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

Biohaven Ltd. will present an investor presentation detailing its ongoing and planned trials for various development programs, including troriluzole, taldefgrobep ...

DelveInsight's Major Depressive Disorder pipeline report depicts a robust space with 75+ active players working to develop ...

Individuals living near golf courses, as well as those who reside in water service areas that include golf courses, are at ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...

Biohaven has started a randomised Phase II/III trial of the TYK2 / JAK1 inhibitor, BHV-8000, aimed at treating early ...

In addition to TD Cowen, Biohaven Ltd. also received a Buy from William Blair’s Myles Minter in a report issued today. However, yesterday, RBC Capital maintained a Hold rating on Biohaven Ltd. (NYSE: ...